英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

enfranchisement    
n. 选举权的给与;解放

选举权的给与;解放

enfranchisement
n 1: freedom from political subjugation or servitude
2: a statutory right or privilege granted to a person or group
by a government (especially the rights of citizenship and the
right to vote) [synonym: {franchise}, {enfranchisement}]
3: the act of certifying or bestowing a franchise on [synonym:
{certification}, {enfranchisement}] [ant:
{disenfranchisement}]


请选择你想看的字典辞典：
单词字典翻译
enfranchisement查看　enfranchisement　在百度字典中的解释百度英翻中〔查看〕
enfranchisement查看　enfranchisement　在Google字典中的解释Google英翻中〔查看〕
enfranchisement查看　enfranchisement　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Connecting the Dots: NTRK-driven lung cancer
    For NTRK-positive lung cancer patients, the results were encouraging, with many experiencing rapid and durable responses As progress continued, attention turned to resistance In 2021, Dr Drilon and Dr Emiliano Cocco identified a new resistance mechanism publishing their findings in prestigious Nature Medicine
  • NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK . . .
    The detection of NTRK gene fusion is recommended by the National Comprehensive Cancer Network (NCCN) clinical practice guidelines, and the TRK inhibitors (larotrectinib and entrectinib) are preferred as the first-line treatment for locally advanced or metastatic patients with NTRK-fusion-positive NSCLC (8)
  • NTRK and Lung Cancer - American Lung Association
    NTRK is an important biomarker that can impact lung what treatment options Dr Robert Doebele explains what an NTRK gene fusion is in cancer NTRK is an important biomarker that can impact lung what treatment options The videos above were produced in 2020 For the latest treatment options, speak with your doctor
  • NTRK Fusion-positive Non–small-cell Lung . . . - Clinical Lung Cancer
    In cases of non–small-cell lung cancer (NSCLC), molecular-targeted therapy has shown remarkable improvements in the survival and safety compared with conventional chemotherapy Recently, the tropomyosin receptor kinase (TRK) inhibitors entrectinib and larotrectinib were approved in the United States, Europe, and elsewhere for patients with a neurotrophic tropomyosin-related kinases (NTRK
  • NTRK Lung Cancer - GO2 for Lung Cancer - go2. org
    Learn about the NTRK gene fusion and its relationship to lung cancer Read about diagnosis, treatment, and what to expect during different treatment plans
  • What is NTRK positive (NTRK+) Lung Cancer?
    If you have non-small cell lung cancer and your tumor tested positive for the NTRK biomarker, you have NTRK+ (NTRK positive) lung cancer This fact sheet explains what this means and how it may affect lung cancer treatment WHAT IS NTRK? NTRK (neurotrophic tyrosine receptor kinase) is a gene that can can move or fuse to another gene
  • NTRK gene fusion testing and management in lung cancer
    This review highlights the importance of testing for NTRK gene fusions in lung cancer, ideally using the gold-standard method of RNA-based NGS, the various assays that are available, and treatment algorithms for patients
  • NTRK Therapy among Different Types of Cancers, Review and Future . . .
    NTRK therapy has emerged as a promising treatment option for cancer patients with NTRK fusion-positive tumors Following the landmark NAVIGATE clinical trials, the development of first- and second-generation NTRK inhibitors transformed the treatment landscape, providing superior clinical outcomes, greater quality of life, and longer survival
  • NTRK Fusions in Cancer – MyPathologyReport
    For patients with advanced lung, colorectal, or pancreatic cancer in whom an NTRK fusion is identified, TRK inhibitor therapy represents one of the most effective targeted treatment options available for any cancer at that stage
  • Updated efficacy and safety of entrectinib in - Lung Cancer
    NTRK fusions result in constitutively active oncogenic TRK proteins responsible for ∼ 0 2 % of non-small cell lung cancer (NSCLC) cases Approximately 40 % of patients with advanced NSCLC develop CNS metastases; therefore, treatments with intracranial (IC) efficacy are needed





中文字典-英文字典  2005-2009